Feed EXFY
EX

Expensify, Inc. EXFY · NASDAQ

$2.59 +1.57% (+$0.04)

Summary

46 / 100 · Bulios Score

What speaks for it

  • It has no debt and holds $65.8M in cash.
  • It bought back its own shares for $9.10M in the last fiscal year, 3.7% of its market value.

What to watch

  • The company made a loss over the last 12 months.
  • Revenue fell by 5.7% a year over the last 3 years.
  • The share price is above the Bulios Fair Price.
  • It passes only 3 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $2.59

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 10% a year over 5 years. Over the last 3 years it fell by 5.7% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $15.6M.

Profitability in detail

Is it financially healthy?

Yes

It has no debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $13.75 is 431% above today's price. 50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Subscription Fees brings in 86% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy